Erratum: IL-37 protects against obesity-induced inflammation and insulin resistance (Nature Communications (2014) 5 (4711) doi: 10.1038/ncomms5711);IL-37 protects against obesity-induced inflammation and insulin resistance

Nature Communications

Volumn 5, Issue , 2014, Pages

  Ballak, Dov B ^a   Van Diepen, Janna A ^a   Moschen, Alexander R ^b   Jansen, Henry J ^a   Hijmans, Anneke ^a   Groenhof, Gert Jan ^a   Leenders, Floris ^a   Bufler, Philip ^b   Boekschoten, Mark V ^c   Müller, Michael ^c   Kersten, Sander ^c   Li, Suzhao ^d   Kim, SooHyun ^e   Eini, Hadar ^f   Lewis, Eli C ^f   Joosten, Leo A B ^a   Tilg, Herbert ^g   Netea, Mihai G ^a   Tack, Cees J ^a   Dinarello, Charles A ^a,d   Stienstra, Rinke ^a,c   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MUNICH   (Germany)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e Konkuk University   (South Korea)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOKINE; FATTY ACID; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 37; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, MOUSE; FAT INTAKE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ENZYME ACTIVITY; GLUCOSE; OBESITY; RNA; SIGNALING;

ADIPOCYTE; ADIPOGENESIS; AFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIVER WEIGHT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEADY STATE; SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BLOOD; DRUG EFFECTS; FAT INTAKE; GENETICS; GLUCOSE TOLERANCE TEST; LIPID DIET; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PRIMARY CELL CULTURE; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIETARY FATS; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; OBESITY; PRIMARY CELL CULTURE;

EID: 84907356510     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7039     Document Type: Erratum

References (62)

1. WHO. WHO Fact Files: Ten Facts on Obesity (WHO, 2010).
2. Sun, K., Kusminski, C. M. & Scherer, P. E. Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101 (2011).
3. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
4. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
5. Schipper, H. S., Prakken, B., Kalkhoven, E. & Boes, M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23, 407-415 (2012).
6. Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445 (2011).
7. Odegaard, J. I. & Chawla, A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat. Clin. Pract. Endocrinol. Metab. 4, 619-626 (2008).
8. Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (New York, NY 271, 665-668 (1996).
9. Jager, J., Gremeaux, T., Cormont, M., Le Marchand-Brustel, Y. & Tanti, J. F. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148, 241-251 (2007).
10. Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246 (2010).
11. Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107 (2011).
12. Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732 (2011).
13. Um, J. Y., Rim, H. K., Kim, S. J., Kim, H. L. & Hong, S. H. Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLoS ONE 6, e29524 (2011).
14. Tack, C. J., Stienstra, R., Joosten, L. A. & Netea, M. G. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol. Rev. 249, 239-252 (2012).
15. Stienstra, R. et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell. Metab. 12, 593-605 (2010).
16. McGillicuddy, F. C. et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 60, 1688-1698 (2011).
17. Spranger, J. et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817 (2003).
18. Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526 (2007).
19. Netea, M. G. et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med. 12, 650-656 (2006).
20. Kumar, S. et al. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 275, 10308-10314 (2000).
21. Nold, M. F. et al. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11, 1014-1022 (2011).
22. Dinarello, C. A. & Bufler, P. Interleukin-37. Semin. Immunol. 25, 466-468 (2013).
23. Dunn, E., Sims, J. E., Nicklin, M. J. & O'Neill, L. A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22, 533-536 (2001).
24. Pan, G. et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 13, 1-7 (2001).
25. Busfield, S. J. et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 66, 213-216 (2000).
26. Smith, D. E. et al. Four new members expand the interleukin-1 superfamily. J. Biol. Chem. 275, 1169-1175 (2000).
27. Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E. & Sims, J. E. Genomic organization of the interleukin-1 locus. Genomics 79, 726-733 (2002).
28. Sharma, S. et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J. Immunol. 180, 5477-5482 (2008).
29. Bulau, A. M. et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc. Natl Acad. Sci. USA 111, 2650-2655 (2014).
30. Bufler, P., Gamboni-Robertson, F., Azam, T., Kim, S. H. & Dinarello, C. A. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem. J. 381, 503-510 (2004).
31. McNamee, E. N. et al. Interleukin 37 expression protects mice from colitis. Proc. Natl Acad. Sci. USA 108, 16711-16716 (2011).
32. Bartelt, A. et al. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17, 200-205 (2011).
33. Ozcan, U. et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (New York, NY) 306, 457-461 (2004).
34. Tanti, J. F. & Jager, J. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 9, 753-762 (2009).
35. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006).
36. Lee, J. Y. et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279, 16971-16979 (2004).
37. Caricilli, A. M. et al. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J. Endocrinol. 199, 399-406 (2008).
38. Orr, J. S. et al. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727 (2012).
39. Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262 (2012).
40. Sag, D., Carling, D., Stout, R. D. & Suttles, J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an antiinflammatory functional phenotype. J. Immunol. 181, 8633-8641 (2008).
41. Ceddia, R. B. The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol. Cell. Endocrinol. 366, 194-203 (2013).
42. Lee, H., Kang, R., Bae, S. & Yoon, Y. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/beta-catenin pathway in 3T3-L1 adipocytes. Int. J. Mol. Med. 28, 65-71 (2011).
43. Moschen, A. R. et al. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol. Med. (Cambridge, MA) 17, 840-845 (2011).
44. O'Neill, L. A. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346-355 (2013).
45. Lindegaard, B. et al. Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice. Diabetes 62, 3064-3074 (2013).
46. Schaffler, A. & Scholmerich, J. Innate immunity and adipose tissue biology. Trends Immunol. 31, 228-235 (2010).
47. Nguyen, M. T. et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292 (2007).
48. Kumar, S. et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18, 61-71 (2002).
49. Nold, M. F. et al. Interleukin 37 exerts its anti-inflammatory functions by associating with IL-18R alpha and SIGIRR. Cytokine 56, 12 (2011).
50. Riva, F. et al. TIR8/SIGIRR is an interleukin-1 receptor/Toll like receptor family member with regulatory functions in inflammation and immunity. Front. Immunol. 3, 322 (2012).
51. Grenfell, S., Smithers, N., Miller, K. & Solari, R. Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem. J. 264, 813-822 (1989).
52. Wessendorf, JH GS., Zhan, X., Brown, S. & Maciag, T. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J. Biol. Chem. 268, 22100-22104 (1993).
53. Arita, Y. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83 (1999).
54. Engeli, S. et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52, 942-947 (2003).
55. Maedler, K. et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55, 2713-2722 (2006).
56. Rothe, H. et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J. Immunol. 163, 1230-1236 (1999).
57. Maedler, K. et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc. Natl Acad. Sci. USA 101, 8138-8143 (2004).
58. Gapp, D. A., Leiter, E. H., Coleman, D. L. & Schwizer, R. W. Temporal changes in pancreatic islet composition in C57BL/6J-db/db (diabetes) mice. Diabetologia 25, 439-443 (1983).
59. Gonzalez, A. et al. Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual beta-cells. Endocrinology 154, 3515-3524 (2013).
60. Milburn, Jr J. L. et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J. Biol. Chem. 270, 1295-1299 (1995).
61. Meneses, M. E. et al. Postprandial inflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models. Mol. Nutr. Food Res. 55, 1759-1770 (2011).
62. Fischer-Posovszky, P., Newell, F. S., Wabitsch, M. & Tornqvist, H. E. Human SGBS cells - a unique tool for studies of human fat cell biology. Obes. Facts 1, 184-189 (2008).